In this thread, I will tell you how to learn python for data science in 1 hour 👇 1/N

It's not possible 2/N

It's not possible 3/N

It's not possible 4/N

It's not possible 5/N

It's not possible 6/N

It's not possible 7/N

It's not possible 8/N

It's not possible 9/N

It's not possible 10/N

More from Machine learning

Roger Grosse
@RogerGrosse

Important paper from Google on large batch optimization. They do impressively careful experiments measuring # iterations needed to achieve target validation error at various batch sizes. The main "surprise" is the lack of surprises. [thread]

https://t.co/7QIx5CFdfJ

The paper is a good example of lots of elements of good experimental design. They validate their metric by showing lots of variants give consistent results. They tune hyperparamters separately for each condition, check that optimum isn't at the endpoints, and measure sensitivity.

They have separate experiments where the hold fixed # iterations and # epochs, which (as they explain) measure very different things. They avoid confounds, such as batch norm's artificial dependence between batch size and regularization strength.

When the experiments are done carefully enough, the results are remarkably consistent between different datasets and architectures. Qualitatively, MNIST behaves just like ImageNet.

Importantly, they don't find any evidence for a "sharp/flat optima" effect whereby better optimization leads to worse final results. They have a good discussion of experimental artifacts/confounds in past papers where such effects were reported.

Ram Bhupatiraju
@RamBhupatiraju

Happy 2⃣0⃣2⃣1⃣ to all.🎇

For any Learning machines out there, here are a list of my fav online investing resources. Feel free to add yours.

Let's dive in.
⬇️⬇️⬇️

Investing Services

✔️ @themotleyfool - @TMFStockAdvisor & @TMFRuleBreakers services

✔️ @7investing

✔️ @investing_city
https://t.co/9aUK1Tclw4

✔️ @MorningstarInc Premium

✔️ @SeekingAlpha Marketplaces (Check your area of interest, Free trials, Quality, track record...)

General Finance/Investing

✔️ @morganhousel
https://t.co/f1joTRaG55

✔️ @dollarsanddata
https://t.co/Mj1owkzRc8

✔️ @awealthofcs
https://t.co/y81KHfh8cn

✔️ @iancassel
https://t.co/KEMTBHa8Qk

✔️ @InvestorAmnesia
https://t.co/zFL3H2dk6s

✔️

Tech focused

✔️ @stratechery
https://t.co/VsNwRStY9C

✔️ @bgurley
https://t.co/NKXGtaB6HQ

✔️ @CBinsights
https://t.co/H77hNp2X5R

✔️ @benedictevans
https://t.co/nyOlasCY1o

✔️

Tech Deep dives

✔️ @StackInvesting
https://t.co/WQ1yBYzT2m

✔️ @hhhypergrowth
https://t.co/kcLKITRLz1

✔️ @Beth_Kindig
https://t.co/CjhLRdP7Rh

✔️ @SeifelCapital
https://t.co/CXXG5PY0xX

✔️ @borrowed_ideas

$Prashant \U0001f4da$

Prashant 📚
@capeandcode

Ever heard of Autoencoders?

The first time I saw a Neural Network with more output neurons than in the hidden layers, I couldn't figure how it would work?!

#DeepLearning #MachineLearning
Here's a little something about them: 🧵👇

Autoencoders are unsupervised neural networks whose architecture you can picture as two funnels connect from the narrow ends.

These networks are primary focus for compression tasks of data in Machine Learning.

We feed them the data so that they can learn the most important features, a smaller representation while keep the integrity of the data.

Later when someone needs, can just take that small representation and recreate the original, just like a zip file.📥

Being unsupervised, they require no labels.
Our inputs and outputs are same and a simple euclidean distance can be used as a loss function for measuring the reconstruction.

Of course, we wouldn't expect a perfect reconstruction.

We can think of an autoencoder having two components, encoder and decoder, represented by the below equations:

We are just trying to minimize the L here. All the backpropagation rules still hold.

Pratham Prasoon
@PrasoonPratham

How to learn Python for machine learning. 🐍

The beginner's guide.
(based on my real life experience of mentoring 300+ students)

🧵👇

In this thread we'll look at all the concepts in Python you need to know for machine learning along with all the free resources that you'll need.

All of this is based on my experience of successfully teaching 300+ students how to code using Python.

(2 / 19)

You can use many languages for machine learning, why Python?

Because of 2 reasons:
- Comparatively easier to learn than other languages
- Has the biggest and most mature community

This makes Python a no-brainer to learn for machine learning as a beginner.

(3 / 19)

These are the absolute basics which you must know about:

- Basic terminal commands
- Basic arithmetic (+,-,/,*)
- Accepting user input
- For & While loops
- Exception handling
- If-Else statements
- Functions, modules & Imports

(4 / 19)

Then comes the more tougher concepts which you must know about:

- Object oriented programming in Python:Classes, Objects, Methods
- PIP (Pypi)
- List slicing
- String formatting
- Dictionaries & Tuples
- Managing environments
- Dunder methods like __init__

(5 / 19)

$Fionna O'Leary, \U0001f56f\U0001f1ea\U0001f1fa$

Fionna O'Leary, 🕯🇪🇺...
@fascinatorfun

Thanks for this incredibly helpful analysis @dgurdasani1

Two questions. 1/ Does this summarise the AZ published data :
The plan is to extend the time interval for all age groups despite it being largely untested on the over 55yrs, although the full data is not yet published

SUMMARY: the Oxford/Astra trial examined dosing with gaps between 4-12 wks- although longer gaps appear to be limited mostly to younger participants. There was no difference reported in published data between these & efficacy from the 1st dose seems high for severe disease.
— Deepti Gurdasani (@dgurdasani1) December 31, 2020

Do we have the actual numbers of over 55yr olds given a 2nd dose at c12 weeks and the accompanying efficacy data?

Not to mention the efficacy data of the full first dose over that same period?

I’d quite like to know whether I am to be a guinea pig & the ongoing risks to manage

You attached photos of excerpts from a paper. Could you attach the link?

Re Pfizer. As I understand it the most efficacious interval for dosing was investigated at the start of the trial.

Discussions of 1 vs 2 doses suggest many are not aware of Pfizer's trials which evaluated 1 vs 2 dose immunogenicity, assessed multiple formulations (BNT162b1 BNT162b2 etc) & conducted dose-ranging in both young & old adults at the start. Saw "clear benefit of booster at day 21" pic.twitter.com/mpyxu9xFSF
— Dr Nicole E Basta (@IDEpiPhD) December 31, 2020

Here’s the link to the

I’ve got to say that this way of making and announcing decisions is not inspiring confidence in me and I am very pro vaccination as a matter of principle, not least because my brother caught polio before vaccinations available.